Literature DB >> 26823869

Investigation on the association between inerleukin-10 -592C/A, 819C/T and -1082A/G gene polymorphisms and development of diabetic nephrophathy.

Qingfeng Yin1, Qianqian Zhai1, Di Wang1, Jie Hai1, Meng Cao1, Jianling Wang1, Tao Wang1.   

Abstract

We conducted a case-control study to investigate the association between interleukin (IL)-10-592C/A, -819C/T and -1082A/G polymorphisms and susceptibility to diabetic nephropathy. A hospital-based case-control study was taken in our study. A total of 172 patients with proven type 2 diabetes mellitus and 344 controls were recruited from the First Affiliated Hospital of Xinxiang Medical University between March 2012 and October 2014. Genotyping of IL-10 -592C/A, -819C/T and -1082A/G polymorphisms was done by done by PCR-RFLP methods. By the χ(2) test, the distributions of the GG, GA and AA genotypes in IL-10 -1082A/G were significantly different between patients with diabetic nephropathy and control subjects (χ(2) = 8.09, P = 0.02). By conditional logistic regression analysis, we found that the AA genotype of IL-10 -1082A/G was associated with an elevated risk of diabetic nephropathy compared to the GG genotype in codominant model, and the adjusted OR (95% CI) was 2.38 (1.23-4.57). In dominant model, the GA+AA genotype was associated with a significantly increased risk of diabetic nephropathy compared to the GG genotype in dominant model (OR = 1.47, 95% CI = 1.05-2.16). In recessive model, the AA genotype could influence the susceptibility to diabetic nephropathy when compared with the GG+GA in recessive model (OR = 2.08, 95% CI = 1.12-3.85). In conclusion, we suggested that IL-10 -1082A/G gene polymorphism was correlated with development of diabetic nephropathy, but no association was observed between IL-10 -819T/C and -592A/C and risk of diabetic nephropathy.

Entities:  

Keywords:  Diabetic nephropathy; IL-10 -1082A/G; IL-10 -592A/C; IL-10 -819T/C; polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26823869      PMCID: PMC4713655     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  15 in total

Review 1.  The role of inflammation as a pathogenic factor in the development of renal disease in diabetes.

Authors:  Carmen Mora; Juan F Navarro
Journal:  Curr Diab Rep       Date:  2005-12       Impact factor: 4.810

2.  Interleukin-10 (-1082G/A) gene polymorphism in patients with type 2 diabetes with and without nephropathy.

Authors:  Mehmet Erdogan; Sevki Cetinkalp; Ahmet Gokhan Ozgen; Fusun Saygili; Afig Berdeli; Candeger Yilmaz
Journal:  Genet Test Mol Biomarkers       Date:  2011-08-23

3.  Interleukin (IL)-10 gene polymorphisms are associated with type 2 diabetes with and without nephropathy: a study of patients from the southeast region of Iran.

Authors:  Mohammad Kazemi Arababadi; Mohammad Reza Mirzaei; Seyed Mohammad Ali Sajadi; Gholamhossein Hassanshahi; Behzad Nasiri Ahmadabadi; Vajihe Akbarpour Salehabadi; Reza Derakhshan; Derek Kennedy
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

4.  [The research on the relationship between the polymorphism of 1082A/G, anti-inflammatory interleukin-10 gene promoter with its effect of preventing ESRD patients from microinflammation and arteriosclerosis].

Authors:  Hong-chi Wu; Hong Ling; Shi-ping Na; Ru-juan Xie
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2005-08-03

5.  High levels of circulating interleukin-10 in diabetic nephropathy patients.

Authors:  Jolanta Myśliwska; K Zorena; E Semetkowska-Jurkiewicz; D Rachoń; H Suchanek; A Myśliwski
Journal:  Eur Cytokine Netw       Date:  2005-06       Impact factor: 2.737

6.  Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study.

Authors:  Peter Rossing; Philip Hougaard; Hans-Henrik Parving
Journal:  Diabetes Care       Date:  2002-05       Impact factor: 19.112

Review 7.  Is type II diabetes mellitus a disease of the innate immune system?

Authors:  J C Pickup; M A Crook
Journal:  Diabetologia       Date:  1998-10       Impact factor: 10.122

8.  Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients.

Authors:  Intissar Ezzidi; Nabil Mtiraoui; Maha Kacem; Samir G Mallat; Manel Ben Hadj Mohamed; Molka Chaieb; Touhami Mahjoub; Wassim Y Almawi
Journal:  Clin Endocrinol (Oxf)       Date:  2008-06-27       Impact factor: 3.478

9.  Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients.

Authors:  Nabil Mtiraoui; Intissar Ezzidi; Maha Kacem; Manel Ben Hadj Mohamed; Molka Chaieb; Aoutef Bel Haj Jilani; Touhami Mahjoub; Wassim Y Almawi
Journal:  Diabetes Metab Res Rev       Date:  2009-01       Impact factor: 4.876

10.  Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.

Authors:  A D'Andrea; M Aste-Amezaga; N M Valiante; X Ma; M Kubin; G Trinchieri
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

View more
  4 in total

1.  Relationship between IL-10 gene -819C/T polymorphism and the risk of inflammatory bowel disease: a meta-analysis.

Authors:  Haien Wu; JingJing Guo; Yajun He; Hekun Yin; Jianchang Shu
Journal:  Afr Health Sci       Date:  2016-09       Impact factor: 0.927

2.  IL10 haplotypes are associated with diabetic nephropathy susceptibility in patients from western Mexico.

Authors:  Luz E Chavarria-Buenrostro; Jorge Hernandez-Bello; Jose F Muñoz-Valle; Jose Macias-Barragan; Liliana B Hernandez-Carrillo; Jorge F Topete-Reyes; Renato Parra-Michel; Maria G Ramirez-Dueñas; Pedro E Sanchez-Hernandez; Ana L Pereira-Suarez; Eden Oceguera-Contreras; Margarita Montoya-Buelna
Journal:  J Clin Lab Anal       Date:  2018-10-21       Impact factor: 2.352

Review 3.  An association between IL-10 promoter polymorphisms and diabetic nephropathy: a meta-analysis of case-control studies.

Authors:  Norah Htet Htet; Arun Kumar Basavaraj; Cho Naing; Sivalingam Nalliah
Journal:  J Diabetes Metab Disord       Date:  2018-09-01

4.  The association between interleukin-19 concentration and diabetic nephropathy.

Authors:  Li Li; Xu-Gan Jiang; Juan-Yu Hu; ZHeng-Qing Yu; Jian-Yong Xu; Fan Liu; Guang-Chun Zhao; Lei Zhang; Hui-Ming Gu; Si-Jing Zhang; Jin Meng
Journal:  BMC Nephrol       Date:  2017-02-15       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.